Constitutive class I-restricted exogenous presentation of self antigens in vivo.

PubWeight™: 5.21‹?› | Rank: Top 1%

🔗 View Article (PMC 2192761)

Published in J Exp Med on September 01, 1996

Authors

C Kurts1, W R Heath, F R Carbone, J Allison, J F Miller, H Kosaka

Author Affiliations

1: Thymus Biology Unit, Walter and Eliza Hall Institute of Medical Research, Royal Melbourne Hospital, Victoria, Australia.

Articles citing this

(truncated to the top 100)

CD8(+) but not CD8(-) dendritic cells cross-prime cytotoxic T cells in vivo. J Exp Med (2000) 7.46

The induction of tolerance by dendritic cells that have captured apoptotic cells. J Exp Med (2000) 5.74

Class I-restricted cross-presentation of exogenous self-antigens leads to deletion of autoreactive CD8(+) T cells. J Exp Med (1997) 5.72

Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T lymphocytes. J Exp Med (1998) 5.59

Antigen-dependent proliferation of CD4+ CD25+ regulatory T cells in vivo. J Exp Med (2003) 5.23

Induction of a CD8+ cytotoxic T lymphocyte response by cross-priming requires cognate CD4+ T cell help. J Exp Med (1997) 4.01

Cross-presentation by dendritic cells. Nat Rev Immunol (2012) 3.95

Initiation of autoimmune diabetes by developmentally regulated presentation of islet cell antigens in the pancreatic lymph nodes. J Exp Med (1999) 3.85

Transforming growth factor-beta signaling curbs thymic negative selection promoting regulatory T cell development. Immunity (2010) 3.69

Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells. J Exp Med (1998) 3.58

Intraclonal competition limits the fate determination of regulatory T cells in the thymus. Nat Immunol (2009) 3.38

Central tolerance to tissue-specific antigens mediated by direct and indirect antigen presentation. J Exp Med (2004) 3.30

T cells with low avidity for a tissue-restricted antigen routinely evade central and peripheral tolerance and cause autoimmunity. Immunity (2006) 3.02

The CD8alpha(+) dendritic cell is responsible for inducing peripheral self-tolerance to tissue-associated antigens. J Exp Med (2002) 2.93

High levels of a major histocompatibility complex II-self peptide complex on dendritic cells from the T cell areas of lymph nodes. J Exp Med (1997) 2.73

Immune tolerance. Regulatory T cells generated early in life play a distinct role in maintaining self-tolerance. Science (2015) 2.73

PDK1 regulation of mTOR and hypoxia-inducible factor 1 integrate metabolism and migration of CD8+ T cells. J Exp Med (2012) 2.58

CD4+ T cell help impairs CD8+ T cell deletion induced by cross-presentation of self-antigens and favors autoimmunity. J Exp Med (1997) 2.49

Langerhans cells and more: langerin-expressing dendritic cell subsets in the skin. Immunol Rev (2010) 2.44

Control of amino-acid transport by antigen receptors coordinates the metabolic reprogramming essential for T cell differentiation. Nat Immunol (2013) 2.37

Constitutive versus activation-dependent cross-presentation of immune complexes by CD8(+) and CD8(-) dendritic cells in vivo. J Exp Med (2002) 2.32

Major histocompatibility complex class I-restricted cross-presentation is biased towards high dose antigens and those released during cellular destruction. J Exp Med (1998) 2.24

Protein kinase B controls transcriptional programs that direct cytotoxic T cell fate but is dispensable for T cell metabolism. Immunity (2011) 2.17

A broad range of self-reactivity drives thymic regulatory T cell selection to limit responses to self. Immunity (2012) 2.10

DEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8+ T cells in a spectrum of human MHC I haplotypes. Proc Natl Acad Sci U S A (2007) 2.04

Kidney dendritic cell activation is required for progression of renal disease in a mouse model of glomerular injury. J Clin Invest (2009) 2.01

Langerhans cells cross-present antigen derived from skin. Proc Natl Acad Sci U S A (2006) 1.98

Autocrine IL-2 is required for secondary population expansion of CD8(+) memory T cells. Nat Immunol (2011) 1.98

Self-tolerance to the murine homologue of a tyrosinase-derived melanoma antigen: implications for tumor immunotherapy. J Exp Med (2000) 1.90

Peripheral deletion of autoreactive CD8 T cells by cross presentation of self-antigen occurs by a Bcl-2-inhibitable pathway mediated by Bim. J Exp Med (2002) 1.89

Human dendritic cells mediate cellular apoptosis via tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). J Exp Med (1999) 1.88

Aire-dependent production of XCL1 mediates medullary accumulation of thymic dendritic cells and contributes to regulatory T cell development. J Exp Med (2011) 1.87

Cross-tolerance: a pathway for inducing tolerance to peripheral tissue antigens. J Exp Med (1998) 1.83

Immunopathogenic mechanisms in psoriasis. Clin Exp Immunol (2004) 1.82

Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease. Clin Microbiol Rev (2006) 1.81

Local expression of B7-H1 promotes organ-specific autoimmunity and transplant rejection. J Clin Invest (2004) 1.71

Viral and bacterial infections interfere with peripheral tolerance induction and activate CD8+ T cells to cause immunopathology. J Exp Med (1998) 1.70

The dendritic cell receptor DNGR-1 controls endocytic handling of necrotic cell antigens to favor cross-priming of CTLs in virus-infected mice. J Clin Invest (2012) 1.69

Therapeutic targeting of Syk in autoimmune diabetes. J Immunol (2010) 1.69

Retracted Reprogrammed FoxP3+ T regulatory cells become IL-17+ antigen-specific autoimmune effectors in vitro and in vivo. J Immunol (2008) 1.69

In situ tolerance within the central nervous system as a mechanism for preventing autoimmunity. J Exp Med (2000) 1.60

The stromal and haematopoietic antigen-presenting cells that reside in secondary lymphoid organs. Nat Rev Immunol (2010) 1.60

MARCH1-mediated MHCII ubiquitination promotes dendritic cell selection of natural regulatory T cells. J Exp Med (2013) 1.57

The impact of negative selection on thymocyte migration in the medulla. Nat Immunol (2009) 1.56

CD8 T cell ignorance or tolerance to islet antigens depends on antigen dose. Proc Natl Acad Sci U S A (1999) 1.55

How defects in central tolerance impinge on a deficiency in regulatory T cells. Proc Natl Acad Sci U S A (2005) 1.55

Batf3-dependent dendritic cells in the renal lymph node induce tolerance against circulating antigens. J Am Soc Nephrol (2013) 1.54

Cross-presentation of glycoprotein 96-associated antigens on major histocompatibility complex class I molecules requires receptor-mediated endocytosis. J Exp Med (2000) 1.54

CD4+CD25-LAG3+ regulatory T cells controlled by the transcription factor Egr-2. Proc Natl Acad Sci U S A (2009) 1.52

Antibody-enhanced cross-presentation of self antigen breaks T cell tolerance. J Clin Invest (2007) 1.51

In vivo blockade of CTLA-4 enhances the priming of responsive T cells but fails to prevent the induction of tumor antigen-specific tolerance. Proc Natl Acad Sci U S A (1999) 1.48

The peripheral deletion of autoreactive CD8+ T cells induced by cross-presentation of self-antigens involves signaling through CD95 (Fas, Apo-1). J Exp Med (1998) 1.47

Role of antigen-presenting cells in mediating tolerance and autoimmunity. J Exp Med (2000) 1.46

Impaired thymic expression of tissue-restricted antigens licenses the de novo generation of autoreactive CD4+ T cells in acute GVHD. Blood (2015) 1.43

Ontogeny of T cell tolerance to peripherally expressed antigens. Proc Natl Acad Sci U S A (1999) 1.43

Avidity maturation of memory CD8 T cells is limited by self-antigen expression. J Exp Med (2008) 1.38

CD40 stimulation leads to effective therapy of CD40(-) tumors through induction of strong systemic cytotoxic T lymphocyte immunity. Proc Natl Acad Sci U S A (2002) 1.34

IL-12 is required for differentiation of pathogenic CD8+ T cell effectors that cause myocarditis. J Clin Invest (2003) 1.31

Immunotherapy with dendritic cells directed against tumor antigens shared with normal host cells results in severe autoimmune disease. J Exp Med (2000) 1.31

Antigen-pulsed CD8alpha+ dendritic cells generate an immune response after subcutaneous injection without homing to the draining lymph node. J Exp Med (1999) 1.28

An optimized CD4 T-cell response can control productive and latent gammaherpesvirus infection. J Virol (2004) 1.28

Dendritic cells infiltrating tumors cotransduced with granulocyte/macrophage colony-stimulating factor (GM-CSF) and CD40 ligand genes take up and present endogenous tumor-associated antigens, and prime naive mice for a cytotoxic T lymphocyte response. J Exp Med (1999) 1.26

In autoimmune diabetes the transition from benign to pernicious insulitis requires an islet cell response to tumor necrosis factor alpha. J Exp Med (1999) 1.25

B cells directly tolerize CD8(+) T cells. J Exp Med (1998) 1.20

Amplification of autoimmune response through induction of dendritic cell maturation in inflamed tissues. J Immunol (2009) 1.18

Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) can regulate dendritic cell-induced activation and cytotoxicity of CD8(+) T cells independently of CD4(+) T cell help. J Exp Med (1999) 1.18

Recombinant Newcastle disease virus as a vaccine vector for cancer therapy. Mol Ther (2008) 1.16

BLT1-mediated T cell trafficking is critical for rejection and obliterative bronchiolitis after lung transplantation. J Exp Med (2005) 1.16

Antigen processing and remodeling of the endosomal pathway: requirements for antigen cross-presentation. Front Immunol (2012) 1.15

TRAIL gene therapy: from preclinical development to clinical application. Curr Gene Ther (2009) 1.13

Langerhans cells are not required for the CD8 T cell response to epidermal self-antigens. J Immunol (2009) 1.12

CCR7-mediated migration of developing thymocytes to the medulla is essential for negative selection to tissue-restricted antigens. Proc Natl Acad Sci U S A (2009) 1.12

Peptide-MHC heterodimers show that thymic positive selection requires a more restricted set of self-peptides than negative selection. J Exp Med (2010) 1.12

IFN-gamma action on pancreatic beta cells causes class I MHC upregulation but not diabetes. J Clin Invest (1998) 1.11

Autoimmunity in MFG-E8-deficient mice is associated with altered trafficking and enhanced cross-presentation of apoptotic cell antigens. J Clin Invest (2011) 1.11

CD4+ CD25+ Treg: divide and rule? Immunology (2004) 1.11

The use of mouse models to better understand mechanisms of autoimmunity and tolerance. J Autoimmun (2010) 1.08

Role of T cells and dendritic cells in glomerular immunopathology. Semin Immunopathol (2007) 1.08

The BH3-only proteins Bim and Puma cooperate to impose deletional tolerance of organ-specific antigens. Immunity (2012) 1.08

Effector CD4 cells are tolerized upon exposure to parenchymal self-antigen. J Immunol (2002) 1.08

Release of endogenous danger signals from HIFU-treated tumor cells and their stimulatory effects on APCs. Biochem Biophys Res Commun (2005) 1.07

Herpes simplex virus type 1-specific cytotoxic T-lymphocyte arming occurs within lymph nodes draining the site of cutaneous infection. J Virol (2000) 1.07

Islet beta-cell-specific T cells can use different homing mechanisms to infiltrate and destroy pancreatic islets. Am J Pathol (2007) 1.07

A safeguard eliminates T cell receptor gene-modified autoreactive T cells after adoptive transfer. Proc Natl Acad Sci U S A (2008) 1.06

Intercellular transfer of MHC and immunological molecules: molecular mechanisms and biological significance. Am J Transplant (2007) 1.06

Real-time immune cell interactions in target tissue during autoimmune-induced damage and graft tolerance. J Exp Med (2014) 1.05

Immunological ignorance of solid tumors. Springer Semin Immunopathol (2005) 1.05

Mannose receptor polyubiquitination regulates endosomal recruitment of p97 and cytosolic antigen translocation for cross-presentation. Proc Natl Acad Sci U S A (2011) 1.05

SOCS-1 regulates IL-15-driven homeostatic proliferation of antigen-naive CD8 T cells, limiting their autoimmune potential. J Exp Med (2005) 1.04

PD-1, but not PD-L1, expressed by islet-reactive CD4+ T cells suppresses infiltration of the pancreas during type 1 diabetes. Diabetes (2013) 1.04

Proapoptotic protein Bim is differentially required during thymic clonal deletion to ubiquitous versus tissue-restricted antigens. Proc Natl Acad Sci U S A (2012) 1.03

Memory CD8+ T cells exhibit increased antigen threshold requirements for recall proliferation. J Exp Med (2014) 0.98

Interleukin-21 receptor-mediated signals control autoreactive T cell infiltration in pancreatic islets. Immunity (2012) 0.98

Loss of T cell CD98 H chain specifically ablates T cell clonal expansion and protects from autoimmunity. J Immunol (2011) 0.98

In vivo cyclophosphamide and IL-2 treatment impedes self-antigen-induced effector CD4 cell tolerization: implications for adoptive immunotherapy. J Immunol (2004) 0.98

Deletion is neither sufficient nor necessary for the induction of peripheral tolerance in mature CD8+ T cells. Immunology (2006) 0.97

Cutting edge: Extracellular signal-related kinase is not required for negative selection of developing T cells. J Immunol (2009) 0.97

The role of lymphocyte subsets in accelerated diabetes in nonobese diabetic-rat insulin promoter-B7-1 (NOD-RIP-B7-1) mice. J Exp Med (1998) 0.96

An optimized CD8+ T-cell response controls productive and latent gammaherpesvirus infection. J Virol (2005) 0.96

Nuclear receptor Nr4a1 modulates both regulatory T-cell (Treg) differentiation and clonal deletion. Proc Natl Acad Sci U S A (2012) 0.96

Articles cited by this

T cell receptor antagonist peptides induce positive selection. Cell (1994) 18.66

Turnover of naive- and memory-phenotype T cells. J Exp Med (1994) 8.07

MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell (1994) 6.92

Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. Science (1994) 6.73

Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay. J Exp Med (1976) 6.33

A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules. Science (1995) 4.64

Peripheral selection of the T cell repertoire. Science (1991) 4.56

Phagocytic processing of bacterial antigens for class I MHC presentation to T cells. Nature (1993) 4.19

CD44 and its interaction with extracellular matrix. Adv Immunol (1993) 4.04

Class I-restricted processing and presentation of exogenous cell-associated antigen in vivo. J Exp Med (1990) 3.73

A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides. Science (1995) 3.58

Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages. Proc Natl Acad Sci U S A (1993) 3.27

Homing of naive, memory and effector lymphocytes. Curr Opin Immunol (1993) 2.93

Heat shock proteins transfer peptides during antigen processing and CTL priming. Immunogenetics (1994) 2.88

Class I MHC presentation of exogenous soluble antigen via macropinocytosis in bone marrow macrophages. Immunity (1995) 2.77

A new foreign policy: MHC class I molecules monitor the outside world. Immunol Today (1996) 2.67

Cells process exogenous proteins for recognition by cytotoxic T lymphocytes. Science (1988) 2.59

Diabetes in transgenic mice resulting from over-expression of class I histocompatibility molecules in pancreatic beta cells. Nature (1988) 2.46

Cytotoxic T lymphocytes against a soluble protein. Nature (1987) 2.36

Presentation of exogenous antigen with class I major histocompatibility complex molecules. Science (1990) 2.33

Major histocompatibility complex class I presentation of peptides derived from soluble exogenous antigen by a subset of cells engaged in phagocytosis. J Exp Med (1995) 2.24

The pathways of endocytosed transferrin and secretory protein are connected in the trans-Golgi reticulum. J Cell Biol (1988) 2.12

Cross-priming of minor histocompatibility antigen-specific cytotoxic T cells upon immunization with the heat shock protein gp96. J Exp Med (1995) 2.11

Phagocytic processing of exogenous particulate antigens by macrophages for presentation by class I MHC molecules. J Immunol (1994) 2.10

Antigen presentation to cytotoxic T lymphocytes in vivo. J Exp Med (1995) 1.98

H-2 antigen requirements in the in vitro induction of SV40-specific cytotoxic T lymphocytes. J Immunol (1980) 1.72

Minor but not major histocompatibility antigens of thymus epithelium tolerize precursors of cytolytic T cells. Nature (1986) 1.69

The effect of allogeneic presensitization on H-Y graft survival and in vitro cell-mediated responses to H-y antigen. J Exp Med (1976) 1.67

The signal for Golgi retention of bovine beta 1,4-galactosyltransferase is in the transmembrane domain. J Biol Chem (1992) 1.60

Preferential positive selection of V alpha 2+ CD8+ T cells in mouse strains expressing both H-2k and T cell receptor V alpha a haplotypes: determination with a V alpha 2-specific monoclonal antibody. Eur J Immunol (1992) 1.58

Class I and class II MHC gene products differentially affect the fate of V beta 5 bearing thymocytes. J Mol Cell Immunol (1990) 1.50

Homing receptor-bearing thymocytes, an immunocompetent cortical subpopulation. Nature (1985) 1.34

Autoimmunity caused by ignorant CD8+ T cells is transient and depends on avidity. J Immunol (1995) 1.32

Mast cells process bacterial Ags through a phagocytic route for class I MHC presentation to T cells. J Immunol (1996) 1.28

Characterization of the murine heat-stable antigen: an hematolymphoid differentiation antigen defined by the J11d, M1/69 and B2A2 antibodies. Eur J Immunol (1990) 1.21

MHC class I-restricted presentation of exogenous antigen by thymic antigen-presenting cells in vitro and in vivo. J Immunol (1992) 1.09

Exogenous antigens internalized through transferrin receptors activate CD4+ T cells. J Immunol (1993) 1.01

Expression of a gastric autoantigen in pancreatic islets results in non-destructive insulitis after neonatal thymectomy. Eur J Immunol (1995) 0.96

Articles by these authors

High efficiency transformation of E. coli by high voltage electroporation. Nucleic Acids Res (1988) 34.78

T cell receptor antagonist peptides induce positive selection. Cell (1994) 18.66

Cell to cell interaction in the immune response. II. The source of hemolysin-forming cells in irradiated mice given bone marrow and thymus or thoracic duct lymphocytes. J Exp Med (1968) 12.91

Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature (1998) 11.08

Defective TCR expression in transgenic mice constructed using cDNA-based alpha- and beta-chain genes under the control of heterologous regulatory elements. Immunol Cell Biol (1998) 11.07

Cell to cell interaction in the immune response. I. Hemolysin-forming cells in neonatally thymectomized mice reconstituted with thymus or thoracic duct lymphocytes. J Exp Med (1968) 9.67

Thymus and antigen-reactive cells. Transplant Rev (1969) 8.84

Current concepts of the immunological function of the thymus. Physiol Rev (1967) 8.37

Introduction of soluble protein into the class I pathway of antigen processing and presentation. Cell (1988) 8.01

Immunological activity of thymus and thoracic-duct lymphocytes. Proc Natl Acad Sci U S A (1968) 7.49

A receptor for antibody on B lymphocytes. I. Method of detection and functional significance. J Exp Med (1972) 7.47

Class I-restricted cross-presentation of exogenous self-antigens leads to deletion of autoreactive CD8(+) T cells. J Exp Med (1997) 5.72

Cross-presentation, dendritic cells, tolerance and immunity. Annu Rev Immunol (2001) 5.15

Cell to cell interaction in the immune response. 3. Chromosomal marker analysis of single antibody-forming cells in reconstituted, irradiated, or thymectomized mice. J Exp Med (1968) 5.02

Sequences required for expression of Bordetella pertussis virulence factors share homology with prokaryotic signal transduction proteins. Proc Natl Acad Sci U S A (1989) 4.78

Specific inactivation of thymus-derived (T) and non-thymus-derived (B) lymphocytes by 125I-labelled antigen. Nat New Biol (1971) 4.55

Induction of a CD8+ cytotoxic T lymphocyte response by cross-priming requires cognate CD4+ T cell help. J Exp Med (1997) 4.01

The thymus and the precursors of antigen reactive cells. Nature (1967) 3.92

Role of major histocompatibility complex gene products in delayed-type hypersensitivity. Proc Natl Acad Sci U S A (1976) 3.69

Cellular basis of the immunological defects in thymectomized mice. Nature (1967) 3.69

Ectopic expression of the flagellar regulon alters development of the Bordetella-host interaction. Cell (1995) 3.64

BvgAS-mediated signal transduction: analysis of phase-locked regulatory mutants of Bordetella bronchiseptica in a rabbit model. Infect Immun (1994) 3.44

Antigen-induced selective recruitment of circulating lymphocytes. Cell Immunol (1971) 3.35

H-2 gene complex restricts transfer of delayed-type hypersensitivity in mice. Proc Natl Acad Sci U S A (1975) 3.34

Regeneration of thymus grafts. I. Histological and cytological aspects. Transplantation (1965) 3.29

Roles for motility in bacterial-host interactions. Mol Microbiol (1997) 3.16

Cell to cell interaction in the immune response. IV. Site of action of antilymphocyte globulin. J Exp Med (1968) 3.16

Cell-to-cell interaction in the immune response. VI. Contribution of thymus-derived cells and antibody-forming cell precursors to immunological memory. J Exp Med (1971) 3.14

CD8 enhances formation of stable T-cell receptor/MHC class I molecule complexes. Nature (1996) 3.08

T cell-dependent suppression of an anti-hapten antibody response. Transplant Rev (1975) 3.06

Cutting edge: intravenous soluble antigen is presented to CD4 T cells by CD8- dendritic cells, but cross-presented to CD8 T cells by CD8+ dendritic cells. J Immunol (2001) 3.05

Interaction between lymphocytes in immune responses. Cell Immunol (1971) 3.03

Ly and Ia antigen phenotypes of T cells involved in delayed-type hypersensitivity and in suppression. J Exp Med (1976) 3.00

Early embryonic mortality in women. Fertil Steril (1982) 2.92

Cell-to-cell interaction in the immune response. X. T-cell-dependent suppression in tolerant mice. J Exp Med (1974) 2.77

Cross-presentation in viral immunity and self-tolerance. Nat Rev Immunol (2001) 2.76

Fetal loss after implantation. A prospective study. Lancet (1980) 2.73

Dysmyelination in transgenic mice resulting from expression of class I histocompatibility molecules in oligodendrocytes. Nature (1991) 2.67

Screening for receptor ligands using large libraries of peptides linked to the C terminus of the lac repressor. Proc Natl Acad Sci U S A (1992) 2.67

Recombinant Listeria monocytogenes as a live vaccine vehicle for the induction of protective anti-viral cell-mediated immunity. Proc Natl Acad Sci U S A (1995) 2.66

A radioisotopic method to measure delayed type hypersensitivity in the mouse. I. Studies in sensitized and normal mice. Int Arch Allergy Appl Immunol (1975) 2.64

Compartmentalization of bacterial antigens: differential effects on priming of CD8 T cells and protective immunity. Cell (1998) 2.59

Clone-specific T cell receptor antagonists of major histocompatibility complex class I-restricted cytotoxic T cells. J Exp Med (1993) 2.57

Contrast, induction, facilitation, suppression, and conservation. J Exp Anal Behav (1976) 2.50

CD4+ T cell help impairs CD8+ T cell deletion induced by cross-presentation of self-antigens and favors autoimmunity. J Exp Med (1997) 2.49

Diabetes in transgenic mice resulting from over-expression of class I histocompatibility molecules in pancreatic beta cells. Nature (1988) 2.46

Integration of multiple domains in a two-component sensor protein: the Bordetella pertussis BvgAS phosphorelay. EMBO J (1996) 2.41

Cell-associated ovalbumin is cross-presented much more efficiently than soluble ovalbumin in vivo. J Immunol (2001) 2.41

Growth of B-lymphocyte colonies in vitro. J Exp Med (1975) 2.41

Prevention of hypoxia-induced cell death by Bcl-2 and Bcl-xL. Nature (1995) 2.40

Peripheral deletion of self-reactive B cells. Nature (1991) 2.34

The bvgAS locus negatively controls motility and synthesis of flagella in Bordetella bronchiseptica. J Bacteriol (1992) 2.33

The bvgA gene of Bordetella pertussis encodes a transcriptional activator required for coordinate regulation of several virulence genes. J Bacteriol (1989) 2.29

Activation of thymus cells by histocompatibility antigens. Nat New Biol (1971) 2.26

The role of the thymus and recent thymic migrants in the maintenance of the adult peripheral lymphocyte pool. J Exp Med (1998) 2.25

Major histocompatibility complex class I-restricted cross-presentation is biased towards high dose antigens and those released during cellular destruction. J Exp Med (1998) 2.24

Growth of B lymphocyte colonies in vitro from mouse lymphoid organs. Nature (1975) 2.24

Tolerance of class I histocompatibility antigens expressed extrathymically. Nature (1989) 2.19

Transgenic expression of mouse proinsulin II prevents diabetes in nonobese diabetic mice. Diabetes (1997) 2.19

MICROBIOME. A unified initiative to harness Earth's microbiomes. Science (2015) 2.15

Enrichment of specific suppressor T cells and characterization of their surface markers. J Exp Med (1977) 2.13

Development of the Leeds Dependence Questionnaire (LDQ): a questionnaire to measure alcohol and opiate dependence in the context of a treatment evaluation package. Addiction (1994) 2.11

Thymus-derived cells in mouse thoracic duct lymph. Nat New Biol (1971) 2.07

The major histocompatibility complex-restricted antigen receptor on T cells in mouse and man: identification of constant and variable peptides. Cell (1983) 2.04

A mutation in the Bordetella bronchiseptica bvgS gene results in reduced virulence and increased resistance to starvation, and identifies a new class of Bvg-regulated antigens. Mol Microbiol (1997) 2.01

Specific suppressive factors produced by hybridomas derived from the fusion of enriched suppressor T cells and a T lymphoma cell line. J Exp Med (1978) 2.01

The BvgAS virulence control system regulates type III secretion in Bordetella bronchiseptica. Mol Microbiol (1998) 1.99

Characterization of the ovalbumin-specific TCR transgenic line OT-I: MHC elements for positive and negative selection. Immunol Cell Biol (2000) 1.98

The cytotoxic T-cell response to herpes simplex virus type 1 infection of C57BL/6 mice is almost entirely directed against a single immunodominant determinant. J Virol (1999) 1.97

Flagellin gene transcription in Bordetella bronchiseptica is regulated by the BvgAS virulence control system. J Bacteriol (1993) 1.94

Autoimmune diabetes as a consequence of locally produced interleukin-2. Nature (1992) 1.92

Effect of thymectomy in adult mice on immunological responsiveness. Nature (1965) 1.91

Receptor for antibody-antigen complexes used to separate T cells from B cells. Nat New Biol (1972) 1.87

Prevention of diabetes in non-obese diabetic I-Ak transgenic mice. Nature (1990) 1.87

The immune response of normal, irradiated and thymectomized mice to fowl immunoglobulin G as detected by a hemolytic plaque technique. Int Arch Allergy Appl Immunol (1971) 1.85

Pregenomic comparative analysis between bordetella bronchiseptica RB50 and Bordetella pertussis tohama I in murine models of respiratory tract infection. Infect Immun (1999) 1.83

Cross-tolerance: a pathway for inducing tolerance to peripheral tissue antigens. J Exp Med (1998) 1.83